Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022

Chris Shibutani Maintained (BNTX) at Hold with Decreased Target to $206 on, May 24th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-206-on-may-24th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Chris Shibutani of Goldman Sachs, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $255 to $206 on, May 24th, 2022.

Chris has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with Chris's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $195 on, Tuesday, May 10th, 2022
  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $200 on, Friday, April 1st, 2022
  • Simon Baker of "Redburn Partners" Upgraded from Strong Sell to Hold on, Tuesday, February 1st, 2022


These are the ratings of the 2 analyists that currently disagree with Chris


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $298 on, Tuesday, April 12th, 2022
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $300 on, Tuesday, April 5th, 2022

Publication Contributing Sources